ABIN1945018
antibody from antibodies-online
Targeting: CD44
CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1945018 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-CD44 (CD44) (pSer706) antibody
- Antibody type
- Polyclonal
- Antigen
- Other
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- pSer706
- Isotype
- IgG
- Vial size
- 100 μg
Submitted references The core protein of epican, a heparan sulfate proteoglycan on keratinocytes, is an alternative form of CD44.
Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.
The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells.
The multispecific cell adhesion molecule CD44 is represented in reticulocyte cDNA.
Kugelman LC, Ganguly S, Haggerty JG, Weissman SM, Milstone LM
The Journal of investigative dermatology 1992 Dec;99(6):886-91
The Journal of investigative dermatology 1992 Dec;99(6):886-91
Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.
Dougherty GJ, Landorp PM, Cooper DL, Humphries RK
The Journal of experimental medicine 1991 Jul 1;174(1):1-5
The Journal of experimental medicine 1991 Jul 1;174(1):1-5
The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells.
Stamenkovic I, Aruffo A, Amiot M, Seed B
The EMBO journal 1991 Feb;10(2):343-8
The EMBO journal 1991 Feb;10(2):343-8
The multispecific cell adhesion molecule CD44 is represented in reticulocyte cDNA.
Harn HJ, Isola N, Cooper DL
Biochemical and biophysical research communications 1991 Aug 15;178(3):1127-34
Biochemical and biophysical research communications 1991 Aug 15;178(3):1127-34
No comments: Submit comment
No validations: Submit validation data